| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway 3 genes, 7 drugs (DrugBank), 40 diseases shown |
[1] JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 2 | Adrenergic signaling in cardiomyocytes 6 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [1] SCN5A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 3 | African trypanosomiasis 3 genes, 6 drugs (DrugBank), 41 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 4 | AGE-RAGE signaling pathway in diabetic complications 5 genes, 8 drugs (DrugBank), 50 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [2] PRKCD, PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 5 | Alcoholism 8 genes, 3 drugs (DrugBank), 9 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 6 | Aldosterone synthesis and secretion 3 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] PDE2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 7 | Allograft rejection 5 genes, 7 drugs (DrugBank), 49 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 8 | Alzheimer disease 11 genes, 8 drugs (DrugBank), 72 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 9 | Amoebiasis 3 genes, 6 drugs (DrugBank), 41 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 10 | Amphetamine addiction 11 genes, 4 drugs (DrugBank), 59 diseases shown |
[1] DRD1 |
D01044 |
Flupentixol |
[1] 97 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 11 | AMPK signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 12 | Amyotrophic lateral sclerosis (ALS) 11 genes, 8 drugs (DrugBank), 72 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 13 | Antifolate resistance 3 genes, 6 drugs (DrugBank), 53 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 14 | Antigen processing and presentation 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 15 | Apelin signaling pathway 3 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 16 | Apoptosis 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 6 genes, 3 drugs (DrugBank), 8 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| 18 | Asthma 2 genes, 7 drugs (DrugBank), 39 diseases shown |
[1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 19 | Autoimmune thyroid disease 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 20 | Autophagy - animal 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] PRKCD, PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 21 | Axon guidance 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 22 | B cell receptor signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 23 | Bile secretion 1 gene, 1 drug (DrugBank), 12 diseases shown |
[1] NR1H4 |
D00734 |
Ursodeoxycholic acid |
[12] 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
| 24 | C-type lectin receptor signaling pathway 10 genes, 12 drugs (DrugBank), 69 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 25 | Caffeine metabolism 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] XDH |
D00224 |
Allopurinol |
[6] 6, 46, 57, 66, 96, 97 |
| 26 | Calcium signaling pathway 13 genes, 6 drugs (DrugBank), 65 diseases shown |
[2] ADORA2A, PDE1B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] DRD1 |
D01044 |
Flupentixol |
[1] 97 |
| [4] GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 27 | cAMP signaling pathway 15 genes, 4 drugs (DrugBank), 12 diseases shown |
[8] ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
[5] 46, 50, 56, 97, 271 |
| 28 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank), 7 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| 29 | Cell adhesion molecules (CAMs) 5 genes, 4 drugs (DrugBank), 25 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| [1] PDCD1 |
D10316 |
Nivolumab |
[10] 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 30 | Cellular senescence 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 31 | cGMP-PKG signaling pathway 13 genes, 7 drugs (DrugBank), 66 diseases shown |
[5] ADORA1, PDE2A, PDE3A, PDE3B, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] OPRD1 |
D00729 |
Loperamide |
[2] 13, 97 |
| D07113 |
| D08144 |
| D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 32 | Chagas disease (American trypanosomiasis) 6 genes, 8 drugs (DrugBank), 42 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 33 | Chemokine signaling pathway 3 genes, 2 drugs (DrugBank), 9 diseases shown |
[2] JAK2, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| 34 | Cholinergic synapse 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 35 | Circadian entrainment 7 genes, 2 drugs (DrugBank), 13 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [2] MTNR1A, MTNR1B |
D08170 |
Melatonin |
[8] 6, 13, 46, 49, 90, 97, 144, 202 |
| 36 | Cocaine addiction 7 genes, 2 drugs (DrugBank), 9 diseases shown |
[2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 37 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 38 | Complement and coagulation cascades 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] F10 |
D03213 |
Apixaban |
[2] 96, 97 |
| [1] SERPINC1 |
D07510 |
Parnaparin |
[1] 97 |
| 39 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 40 | Cushing syndrome 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 41 | Cytokine-cytokine receptor interaction 13 genes, 17 drugs (DrugBank), 48 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [2] IL17A, IL17F |
D11550 |
Bimekizumab |
[3] 46, 97, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] LTB |
D08866 |
Baminercept |
[4] 13, 46, 53, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 42 | Dilated cardiomyopathy (DCM) 7 genes, 8 drugs (DrugBank), 42 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 43 | Dopaminergic synapse 8 genes, 5 drugs (DrugBank), 63 diseases shown |
[2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [2] GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [3] PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SCN1A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 44 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank), 9 diseases shown |
[1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [1] XDH |
D00224 |
Allopurinol |
[6] 6, 46, 57, 66, 96, 97 |
| 45 | ECM-receptor interaction 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| 46 | EGFR tyrosine kinase inhibitor resistance 2 genes, 4 drugs (DrugBank), 14 diseases shown |
[1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 47 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
[5] 46, 84, 96, 97, 299 |
| 48 | Endocytosis 3 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| 49 | Epstein-Barr virus infection 9 genes, 12 drugs (DrugBank), 45 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 50 | Estrogen signaling pathway 2 genes, 3 drugs (DrugBank), 11 diseases shown |
[1] OPRM1 |
D00729 |
Loperamide |
[2] 13, 97 |
| D07113 |
| D08144 |
| D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| [1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| 51 | Fc epsilon RI signaling pathway 2 genes, 7 drugs (DrugBank), 39 diseases shown |
[1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 52 | Fc gamma R-mediated phagocytosis 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] PRKCD, PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 53 | Fluid shear stress and atherosclerosis 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 54 | Focal adhesion 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| 55 | Folate biosynthesis 4 genes, 2 drugs (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| [2] TPH1, TPH2 |
D09973 |
Telotristat |
[1] 97 |
| 56 | FoxO signaling pathway 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[2] S1PR1, S1PR4 |
D10930 |
Etrasimod |
[1] 97 |
| D10968 |
Ozanimod |
[3] 13, 96, 97 |
| 57 | GABAergic synapse 17 genes, 2 drugs (DrugBank), 12 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [1] SLC6A1 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| 58 | Gap junction 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| 59 | Gastric acid secretion 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 60 | Glucagon signaling pathway 6 genes, 3 drugs (DrugBank), 57 diseases shown |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 61 | Glutamatergic synapse 10 genes, 3 drugs (DrugBank), 59 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 62 | GnRH signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| 63 | Graft-versus-host disease 3 genes, 6 drugs (DrugBank), 49 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 64 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 65 | Hematopoietic cell lineage 7 genes, 12 drugs (DrugBank), 63 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [1] IL2RA |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [1] ITGA4 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 66 | Hepatitis B 6 genes, 10 drugs (DrugBank), 45 diseases shown |
[1] IFNAR1 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [4] JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 67 | Hepatitis C 5 genes, 10 drugs (DrugBank), 45 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 68 | Herpes simplex virus 1 infection 8 genes, 11 drugs (DrugBank), 46 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 69 | Hippo signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SMAD7 |
D10956 |
Mongersen |
[2] 96, 97 |
| 70 | Human cytomegalovirus infection 7 genes, 11 drugs (DrugBank), 69 diseases shown |
[1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 71 | Human immunodeficiency virus 1 infection 9 genes, 9 drugs (DrugBank), 68 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 72 | Human papillomavirus infection 7 genes, 12 drugs (DrugBank), 45 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 73 | Human T-cell leukemia virus 1 infection 14 genes, 16 drugs (DrugBank), 69 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 74 | Huntington disease 3 genes, 2 drugs (DrugBank), 12 diseases shown |
[2] GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 75 | Hypertrophic cardiomyopathy (HCM) 7 genes, 8 drugs (DrugBank), 42 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 76 | IL-17 signaling pathway 4 genes, 8 drugs (DrugBank), 39 diseases shown |
[1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [2] IL17A, IL17F |
D11550 |
Bimekizumab |
[3] 46, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 77 | Inflammatory bowel disease (IBD) 8 genes, 13 drugs (DrugBank), 41 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [2] IL17A, IL17F |
D11550 |
Bimekizumab |
[3] 46, 97, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 78 | Inflammatory mediator regulation of TRP channels 4 genes, 1 drug (DrugBank), 1 disease shown |
[4] PRKCD, PRKCE, PRKCH, PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 79 | Influenza A 8 genes, 11 drugs (DrugBank), 46 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 80 | Insulin resistance 4 genes, 6 drugs (DrugBank), 39 diseases shown |
[3] PRKCD, PRKCE, PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 81 | Insulin signaling pathway 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| 82 | Intestinal immune network for IgA production 4 genes, 3 drugs (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| 83 | JAK-STAT signaling pathway 13 genes, 14 drugs (DrugBank), 28 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [4] JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 84 | Kaposi sarcoma-associated herpesvirus infection 11 genes, 8 drugs (DrugBank), 61 diseases shown |
[1] CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 85 | Legionellosis 3 genes, 6 drugs (DrugBank), 41 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 86 | Leishmaniasis 6 genes, 11 drugs (DrugBank), 44 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] ITGA4 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 87 | Leukocyte transendothelial migration 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ITGA4 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| 88 | Long-term potentiation 10 genes, 3 drugs (DrugBank), 59 diseases shown |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 89 | Longevity regulating pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 90 | Malaria 2 genes, 6 drugs (DrugBank), 41 diseases shown |
[1] IL12A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 91 | MAPK signaling pathway 10 genes, 8 drugs (DrugBank), 70 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 92 | Measles 13 genes, 11 drugs (DrugBank), 27 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 93 | Metabolic pathways 18 genes, 8 drugs (DrugBank), 48 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| [1] GUCY2C |
D09355 |
Linaclotide |
[1] 97 |
| [1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
[5] 46, 50, 56, 97, 271 |
| [2] TPH1, TPH2 |
D09973 |
Telotristat |
[1] 97 |
| [1] XDH |
D00224 |
Allopurinol |
[6] 6, 46, 57, 66, 96, 97 |
| 94 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 95 | Mineral absorption 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
[5] 46, 84, 96, 97, 299 |
| 96 | Morphine addiction 27 genes, 6 drugs (DrugBank), 21 diseases shown |
[9] ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] DRD1 |
D01044 |
Flupentixol |
[1] 97 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [1] OPRM1 |
D00729 |
Loperamide |
[2] 13, 97 |
| D07113 |
| D08144 |
| D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
[5] 46, 50, 56, 97, 271 |
| 97 | mTOR signaling pathway 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 98 | Natural killer cell mediated cytotoxicity 8 genes, 8 drugs (DrugBank), 68 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 99 | Necroptosis 7 genes, 10 drugs (DrugBank), 45 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [4] JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 100 | Neuroactive ligand-receptor interaction 39 genes, 21 drugs (DrugBank), 85 diseases shown |
[2] ADORA1, ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [2] CNR1, CNR2 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [2] MTNR1A, MTNR1B |
D08170 |
Melatonin |
[8] 6, 13, 46, 49, 90, 97, 144, 202 |
| [1] NR3C1 |
D00689 |
Beclomethasone dipropionate |
[2] 97, 98 |
| D07495 |
| D00246 |
Budesonide |
[10] 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
| D00292 |
Dexamethasone |
[20] 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| D00088 |
Hydrocortisone |
[8] 6, 53, 75, 78, 81, 83, 97, 299 |
| D00165 |
Hydrocortisone acetate |
[8] 6, 53, 75, 78, 81, 83, 97, 299 |
| D00407 |
Methylprednisolone |
[36] 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
| D00751 |
| D00979 |
| D05000 |
| D05001 |
| D05002 |
| D05000 |
Methylprednisolone hemisuccinate |
[2] 13, 97 |
| D00472 |
Prednisolone |
[38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| D00385 |
Triamcinolone |
[18] 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
| D00983 |
| D00984 |
| D00985 |
| D06216 |
| [3] OPRD1, OPRK1, OPRM1 |
D00729 |
Loperamide |
[2] 13, 97 |
| D07113 |
| D08144 |
| D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10930 |
Etrasimod |
[1] 97 |
| D10968 |
Ozanimod |
[3] 13, 96, 97 |
| 101 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| 102 | NF-kappa B signaling pathway 3 genes, 7 drugs (DrugBank), 40 diseases shown |
[1] LTB |
D08866 |
Baminercept |
[4] 13, 46, 53, 97 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 103 | Nicotine addiction 21 genes, 2 drugs (DrugBank), 13 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 104 | NOD-like receptor signaling pathway 6 genes, 11 drugs (DrugBank), 45 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PRKCD |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 105 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 106 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 107 | Olfactory transduction 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] PDE1B, PDE2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| 108 | One carbon pool by folate 2 genes, 1 drug (DrugBank), 33 diseases shown |
[2] DHFR, DHFR2 |
D00142 |
Methotrexate |
[33] 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 109 | Oocyte meiosis 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 110 | Osteoclast differentiation 11 genes, 13 drugs (DrugBank), 71 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 111 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 112 | Oxytocin signaling pathway 9 genes, 3 drugs (DrugBank), 58 diseases shown |
[4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 113 | Pancreatic cancer 1 gene, 4 drugs (DrugBank), 14 diseases shown |
[1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| 114 | Parathyroid hormone synthesis, secretion and action 5 genes, 4 drugs (DrugBank), 21 diseases shown |
[4] PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
[5] 46, 50, 56, 97, 271 |
| D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
[5] 46, 84, 96, 97, 299 |
| 115 | Parkinson disease 3 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [2] DRD1, DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| 116 | Pathogenic Escherichia coli infection 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 117 | Pathways in cancer 14 genes, 16 drugs (DrugBank), 41 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 118 | PD-L1 expression and PD-1 checkpoint pathway in cancer 12 genes, 10 drugs (DrugBank), 58 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] PDCD1 |
D10316 |
Nivolumab |
[10] 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 119 | Peroxisome 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] XDH |
D00224 |
Allopurinol |
[6] 6, 46, 57, 66, 96, 97 |
| 120 | Pertussis 4 genes, 9 drugs (DrugBank), 41 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 121 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 122 | PI3K-Akt signaling pathway 10 genes, 10 drugs (DrugBank), 23 diseases shown |
[2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 123 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 124 | Primary immunodeficiency 4 genes, 4 drugs (DrugBank), 12 diseases shown |
[2] CD3D, CD3E |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [1] IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 125 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| 126 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 127 | Proteoglycans in cancer 2 genes, 6 drugs (DrugBank), 41 diseases shown |
[1] IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 128 | Purine metabolism 12 genes, 5 drugs (DrugBank), 14 diseases shown |
[1] GUCY2C |
D09355 |
Linaclotide |
[1] 97 |
| [1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [4] PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
[5] 46, 50, 56, 97, 271 |
| [1] XDH |
D00224 |
Allopurinol |
[6] 6, 46, 57, 66, 96, 97 |
| 129 | Rap1 signaling pathway 6 genes, 4 drugs (DrugBank), 17 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [1] DRD2 |
D01044 |
Flupentixol |
[1] 97 |
| [3] GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 130 | Ras signaling pathway 3 genes, 1 drug (DrugBank), 9 diseases shown |
[3] GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 131 | Regulation of actin cytoskeleton 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[2] ITGA4, ITGB7 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| 132 | Regulation of lipolysis in adipocytes 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ADORA1, PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| 133 | Renin secretion 10 genes, 4 drugs (DrugBank), 63 diseases shown |
[4] ADORA1, PDE1B, PDE3A, PDE3B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 134 | Renin-angiotensin system 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 135 | Retrograde endocannabinoid signaling 17 genes, 2 drugs (DrugBank), 18 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 136 | Rheumatoid arthritis 6 genes, 12 drugs (DrugBank), 49 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] IL17A |
D11550 |
Bimekizumab |
[3] 46, 97, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] LTB |
D08866 |
Baminercept |
[4] 13, 46, 53, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 137 | RIG-I-like receptor signaling pathway 3 genes, 6 drugs (DrugBank), 41 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 138 | Serotonergic synapse 5 genes, 2 drugs (DrugBank), 10 diseases shown |
[3] GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [2] TPH1, TPH2 |
D09973 |
Telotristat |
[1] 97 |
| 139 | Shigellosis 4 genes, 6 drugs (DrugBank), 39 diseases shown |
[3] PRKCD, PRKCE, PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 140 | Signaling pathways regulating pluripotency of stem cells 3 genes, 4 drugs (DrugBank), 14 diseases shown |
[1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 141 | Sphingolipid signaling pathway 9 genes, 11 drugs (DrugBank), 45 diseases shown |
[1] ADORA1 |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] OPRD1 |
D00729 |
Loperamide |
[2] 13, 97 |
| D07113 |
| D08144 |
| D02095 |
Naltrexone |
[11] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| [1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10930 |
Etrasimod |
[1] 97 |
| D10968 |
Ozanimod |
[3] 13, 96, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 142 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank), 7 diseases shown |
[1] SLC6A1 |
D00332 |
Gabapentin |
[7] 6, 13, 19, 70, 97, 226, 298 |
| 143 | Systemic lupus erythematosus 5 genes, 7 drugs (DrugBank), 53 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
[9] 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 144 | T cell receptor signaling pathway 11 genes, 11 drugs (DrugBank), 68 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [1] PDCD1 |
D10316 |
Nivolumab |
[10] 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 145 | Taste transduction 10 genes, 3 drugs (DrugBank), 16 diseases shown |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
[10] 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| [1] PDE1B |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [3] SCN2A, SCN3A, SCN9A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 146 | TGF-beta signaling pathway 2 genes, 6 drugs (DrugBank), 39 diseases shown |
[1] SMAD7 |
D10956 |
Mongersen |
[2] 96, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 147 | Th1 and Th2 cell differentiation 19 genes, 15 drugs (DrugBank), 60 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL13 |
D08857 |
Anrukinzumab |
[1] 97 |
| D09979 |
Tralokinumab |
[2] 85, 97 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [4] JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 148 | Th17 cell differentiation 19 genes, 17 drugs (DrugBank), 60 diseases shown |
[3] CD3D, CD3E, CD3G |
D05092 |
Muromonab |
[3] 60, 96, 97 |
| D06314 |
Visilizumab |
[2] 96, 97 |
| [2] IL17A, IL17F |
D11550 |
Bimekizumab |
[3] 46, 97, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [4] JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 149 | Thermogenesis 2 genes, 2 drugs (DrugBank), 17 diseases shown |
[1] CNR1 |
D10915 |
Cannabidiol |
[14] 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 150 | Thyroid cancer 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 151 | Tight junction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| 152 | TNF signaling pathway 1 gene, 5 drugs (DrugBank), 39 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 153 | Toll-like receptor signaling pathway 7 genes, 8 drugs (DrugBank), 51 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] IFNAR1, IFNAR2 |
D04554 |
Interferon beta-1a |
[5] 13, 14, 26, 96, 97 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 154 | Toxoplasmosis 6 genes, 10 drugs (DrugBank), 44 diseases shown |
[2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [3] JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 155 | Transcriptional misregulation in cancer 4 genes, 5 drugs (DrugBank), 27 diseases shown |
[1] CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [1] IL2RB |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] ITGB7 |
D09901 |
Etrolizumab |
[2] 96, 97 |
| D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 156 | Tryptophan metabolism 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] TPH1, TPH2 |
D09973 |
Telotristat |
[1] 97 |
| 157 | Tuberculosis 12 genes, 17 drugs (DrugBank), 72 diseases shown |
[3] IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] IL23A |
D10438 |
Guselkumab |
[3] 37, 96, 97 |
| D11123 |
Mirikizumab |
[2] 96, 97 |
| D11052 |
Risankizumab |
[4] 37, 96, 97, 271 |
| [1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK2 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| [1] VDR |
D00188 |
Cholecalciferol |
[15] 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
[5] 46, 84, 96, 97, 299 |
| 158 | Type I diabetes mellitus 5 genes, 7 drugs (DrugBank), 49 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| [2] IL12A, IL12B |
D09214 |
Ustekinumab |
[16] 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 159 | Type II diabetes mellitus 3 genes, 6 drugs (DrugBank), 39 diseases shown |
[2] PRKCD, PRKCE |
D09671 |
Sotrastaurin |
[1] 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 160 | Vascular smooth muscle contraction 6 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] ADORA2A |
D00528 |
Caffeine |
[6] 2, 6, 46, 78, 96, 97 |
| D01453 |
| [1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] PRKCD, PRKCE, PRKCH, PRKCQ |
D09671 |
Sotrastaurin |
[1] 97 |
| 161 | VEGF signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 162 | Viral carcinogenesis 2 genes, 4 drugs (DrugBank), 14 diseases shown |
[1] JAK1 |
D10871 |
Filgotinib |
[6] 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
[4] 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
[6] 41, 46, 49, 96, 97, 271 |
| [2] JAK1, JAK3 |
D09970 |
Tofacitinib |
[9] 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 163 | Viral myocarditis 2 genes, 1 drug (DrugBank), 24 diseases shown |
[2] CD80, CD86 |
D03203 |
Abatacept |
[24] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 164 | Viral protein interaction with cytokine and cytokine receptor 4 genes, 8 drugs (DrugBank), 45 diseases shown |
[1] IL2RA |
D03058 |
Basiliximab |
[7] 2, 50, 65, 66, 97, 222, 228 |
| D03639 |
Daclizumab |
[7] 13, 56, 60, 65, 97, 283, 284 |
| [3] IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
[4] 2, 49, 65, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 165 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 166 | Yersinia infection 2 genes, 6 drugs (DrugBank), 39 diseases shown |
[1] ITGA4 |
D08083 |
Vedolizumab |
[2] 96, 97 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
[6] 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
[5] 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D00754 |
Thalidomide |
[18] 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |